Class I indications for indefinite ACEI therapy:
- stable angina pectoris undergoing myocardial revascularisation + LV EF < 40%,
- stable angina pectoris undergoing myocardial revascularisation + hypertension,
- stable angina pectoris undergoing myocardial revascularisation + chronic kidney disease,
- stable angina pectoris undergoing myocardial revascularisation + diabetes mellitus.
Class IIa indications for indefinite ACEI therapy:
- stable angina pectoris undergoing myocardial revascularisation + absence of LV EF < 40% + absence of hypertension + absence of chronic kidney disease + absence of diabetes mellitus.